|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270.10 USD | -3.51% |
|
-6.19% | -11.10% |
| 02/06 | BeOne Medicines Solid Tumor Data Boost Confidence in Long-term Growth, RBC Says | MT |
| 02/06 | RBC Raises Price Target on BeOne Medicines to $436 From $425, Keeps Outperform Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 293.09 | 310.25 | 365.82 |
| Spread/Res. | -7.84% | -12.94% | -26.17% |
| Spread/Supp. | +3.96% | +10.02% | +11.98% |
| Support | 259.81 | 245.49 | 241.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ONC Stock
- Charts BeOne Medicines AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition